Karuna Therapeutics released reassuring phase Ib data mitigating blood pressure concerns with its investigational psychiatric drug KarXT; the novel agent is under review with the FDA for an indication in schizophrenia.
A Massachusetts psychiatrist was convicted for illegally prescribing combinations of benzodiazepines and stimulants, the Department of Justice said.
Texas has sued Pfizer, alleging that the company covered up manufacturing problems with its drug methylphenidate (Quillivant XR) for attention deficit-hyperactivity disorder (ADHD). (Fierce Pharma)
A security guard was killed during a shooting at a New Hampshire psychiatric hospital; no patients were harmed and the suspect was killed, according to authorities. (CNN)
One state-run psychiatric hospital in Hawaii was so crowded, patients were sleeping in conference rooms. (Honolulu Civil Beat)
Amid the growing neurodiversity movement, a rift has developed over the term “profound autism.” (Washington Post)
More generous paid family and medical leave was linked with a significantly lower risk for postpartum depression symptoms. (Obstetrics and Gynecology)
Two former dancers in the Richmond Ballet sued the Virginia company for $21 million in damages for allegedly contributing to their eating disorders. (Axios)
For pregnant and postpartum women between the ages of 35 to 44, the drug overdose mortality ratio more than tripled from 2018 to 2021. (JAMA Psychiatry)
The World Health Organization issued an updated edition of its recommendations for treating mental, neurological, and substance use disorders.
Recent research breakthroughs related to Alzheimer’s treatments have renewed interest in the potential use of vaccines to treat the disease. (Reuters)